医疗器械和手术试验中心力衰竭的表型特征
Kurdo Araz1, Francesco Fioretti2, Sara Ladak1
1School of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
ESC heart failure
|August 26, 2025
概括
医疗器械和外科手术对心力衰竭具有保留的喷射分数 (HFpEF) 是有前途的,但需要更多的研究来确认对患者的长期益处.
科学领域:
- 心脏病学
- 医疗器械
- 进行手术
背景情况:
- 几乎50%的心力衰竭患者患有心力衰竭与保存的喷射分数 (HFpEF).
- HFpEF与老年,肥胖,心房动和高血压有关.
- 目前对HFpEF的治疗方法有限.
研究的目的:
- 评估医疗器械和手术治疗HFpEF的潜力.
- 确定针对性治疗的特定HFpEF表型.
- 审查HFpEF治疗中的新临床试验.
主要方法:
- 使用PRISMA指南进行临床试验的系统审查.
- 纳入标准:患有扩张功能障碍,正在接受医疗器械或手术的高发烧率患者 (LVEF ≥50%).
- 24项试验 (1752名参与者) 的描述性分析和质量评估.
主要成果:
- 确定了17个医疗器械试验和7个手术干预试验.
- 干预包括心脏间的分流,神经刺激,心脏反射激活,心脏收缩调节器,心脏重同步治疗,功能电刺激,神经消化,管消化和心周切除术.
- 在24项试验中,有16项证明了安全性和可行性;大多数仍处于早期阶段.
结论:
- 医疗器械和外科手术证明了HFpEF治疗的概念.
- 目前的证据不足以证明长期的益处.
- 基于证据的HFpEF解决方案需要进一步的基于表型的临床试验.
相关概念视频
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure II: Pathophysiology
38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Heart Failure III: Clinical Manifestations
43
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
43


